Question follow-through · 797
Ehlers-Danlos Syndrome: Health Services
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of NHS care pathways for patients with hypermobile Ehlers-Danlos Syndrome and associated co-morbidities.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 13 May 2026
- Target answer date
- 18 May 2026
- Answer
- 26 May 2026 · 13 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Sodium Valproate · 18 May 2026
- Bipolar Disorder: Medical Treatments · 19 May 2026
- Physician Assistants: Standards · 25 Jun 2026
- Physician and Anaesthesia Associate Professions Independent Review · 25 Jun 2026
- Health Professions: Standards · 25 Jun 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
13 May 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of NHS care pathways for patients with hypermobile Ehlers-Danlos Syndrome and associated co-morbidities.
18 May 2026
Target answer date
Date supplied by the official written-questions record.
26 May 2026
Answer published
In England, the organisation and delivery of multidisciplinary care for patients with hypermobile Ehlers-Danlos syndromes (hEDS) and associated co-morbidities is a matter for local National Health Service systems. Integrated care boards are responsible fo...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Sodium Valproate
18 May 2026 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of appointing a (a) senior team and (b) tsar to support people affected by sodium valproate.
Bipolar Disorder: Medical Treatments
19 May 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of commissioning an expert clinical review into the use of the Zamar Protocol for patients with severe treatment-resistant bipo
Physician Assistants: Standards
25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure clear national standards on the scope of practice and supervision of Physician Associates and Anaesthesia Associates.
Physician and Anaesthesia Associate Professions Independent Review
25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what progress he has made in implementing the recommendations of the independent review of Physician Associate and Anaesthesia Associate roles.
Health Professions: Standards
25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of General Medical Council fitness-to-practise investigations on the wellbeing of doctors, and what steps are being taken to ensure those process
Advice and Guidance Services: Out-patients
25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of mandatory Advice and Guidance pathways on patients' access to hospital specialist care.
Rare Diseases: Advice and Guidance Services
25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what safeguards are in place to ensure that patients with complex, chronic or rare conditions are not disadvantaged by the requirement to use Advice and Guidance before referral.
Muscular Dystrophy: Medical Treatments
29 Jun 2026 · To ask the Secretary of State for Health and Social Care, what funding his Department has allocated for emerging Duchenne muscular dystrophy treatments; and what plans he has to ensure that future therapies, including gene therapies and exon-skipping trea
Hospitals: Standards
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to eradicate corridor care by the end of this Parliament, and whether he plans to publish a costed plan and timetable.
Accident and Emergency Departments: Standards
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, how many patients aged 60 and over waited 12 hours or more in accident and emergency departments in each of the last three years; and what assessment he has made of the effect of 12-hour waits on t
University Hospitals of Leicester NHS Trust: Accident and Emergency Departments
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce accident and emergency waiting times at University Hospitals of Leicester NHS Trust.
ADHD: Health Services
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve national consistency in shared care arrangements for patients prescribed medication for ADHD; and whether he plans to introduce national (a) standards